CUMBERLAND PHARMACEUTICALS INC Quarterly Income Tax Expense (Benefit) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Cumberland Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q3 2024.
  • Cumberland Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $11.4K, a 64.9% increase year-over-year.
  • Cumberland Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $59.3K, a 14% decline year-over-year.
  • Cumberland Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2023 was $45.8K, a 33.5% decline from 2022.
  • Cumberland Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2022 was $68.9K, a 97.3% increase from 2021.
  • Cumberland Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was $34.9K, a 37.6% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $59.3K $11.4K +$4.5K +64.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $54.8K $11.4K +$4.51K +65% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $50.3K $11.4K +$4.5K +64.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $45.8K $25K -$23.2K -48.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $69K $6.94K +$38.00 +0.55% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $68.9K $6.94K +$37.00 +0.54% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $68.9K $6.94K +$38.00 +0.55% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $68.9K $48.2K +$35.6K +285% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $33.2K $6.9K -$558 -7.48% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $33.8K $6.9K -$559 -7.49% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $34.3K $6.9K -$558 -7.48% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $34.9K $12.5K +$2.04K +19.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-13
Q3 2021 $32.9K $7.46K +$3.73K +100% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $29.1K $7.46K +$4.00 +0.05% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $29.1K $7.46K -$26.8K -78.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $55.9K $10.5K +$17.3K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $38.6K $3.73K -$734 -16.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $39.3K $7.46K +$2.99K +67.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $36.4K $34.2K +$116K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$79.3K -$6.81K -$11K -264% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 -$68.3K $4.46K +$303 +7.29% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$68.6K $4.46K +$303 +7.29% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$69K -$81.4K -$85.6K -2058% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-22
Q4 2018 $16.6K $4.16K -$1.29M -99.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 $1.3M $4.16K +$337 +8.82% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $1.3M $4.16K -$3.53M -99.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $4.84M $4.16K +$661K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $4.17M $1.29M +$1.46M Oct 1, 2017 Dec 31, 2017 8-K 2020-12-10
Q3 2017 $2.71M $3.82K -$53.4K -93.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $2.76M $3.54M +$3.58M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$812K -$657K -$481K -274% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$331K -$172K -$217K -482% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-12
Q3 2016 -$114K $57.2K -$136K -70.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $21.9K -$41.1K -$360K -113% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $382K -$175K -$194K -1050% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $576K $44.9K -$283K -86.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 $859K $193K -$148K -43.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $1.01M $319K -$204K -39% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $1.21M $18.5K -$170K -90.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $1.38M $328K +$1.26M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-13
Q3 2014 $120K $341K +$1.03M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$908K $523K +$987K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$1.89M $188K -$371K -66.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$1.52M -$933K -$2.43M -163% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 $902K -$686K -$1.89M -157% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $2.8M -$463K -$726K -276% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $3.52M $559K +$277K +98.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $3.24M $1.49M +$650K +77.3% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-09
Q3 2012 $2.59M $1.21M -$71K -5.55% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-06
Q2 2012 $2.67M $263K -$1.17M -81.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $3.84M $282K -$242K -46.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $4.08M $842K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-11
Q3 2011 $1.28M +$335K +35.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 $1.44M +$1.06M +284% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $524K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 $943K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $374K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.